Literature DB >> 24522687

Aldosterone antagonists in systolic heart failure.

Adrienne J Lindblad, G Michael Allan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24522687      PMCID： PMC3922577     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  12 in total

1.  Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials.

Authors:  S Bonet; A Agustí; J M Arnau; X Vidal; E Diogène; E Galve; J R Laporte
Journal:  Arch Intern Med       Date:  2000-03-13

2.  Eplerenone in patients with systolic heart failure and mild symptoms.

Authors:  Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

3.  Hyperkalemia associated with spironolactone therapy.

Authors:  Lisa Dolovich; Scott Gavura; Kevin Pottie
Journal:  Can Fam Physician       Date:  2005-03       Impact factor: 3.275

4.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

Review 5.  Potential impact of optimal implementation of evidence-based heart failure therapies on mortality.

Authors:  Gregg C Fonarow; Clyde W Yancy; Adrian F Hernandez; Eric D Peterson; John A Spertus; Paul A Heidenreich
Journal:  Am Heart J       Date:  2011-06       Impact factor: 4.749

6.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

7.  Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Authors:  David N Juurlink; Muhammad M Mamdani; Douglas S Lee; Alexander Kopp; Peter C Austin; Andreas Laupacis; Donald A Redelmeier
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

Review 8.  The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.

Authors:  Robert S McKelvie; Gordon W Moe; Justin A Ezekowitz; George A Heckman; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Nadia Giannetti; Adam Grzeslo; Karen Harkness; Jonathan G Howlett; Simon Kouz; Kori Leblanc; Elizabeth Mann; Anil Nigam; Eileen O'Meara; Miroslaw Rajda; Brian Steinhart; Elizabeth Swiggum; Vy Van Le; Shelley Zieroth; J Malcolm O Arnold; Tom Ashton; Michel D'Astous; Paul Dorian; Haissam Haddad; Debra L Isaac; Marie-Hélène Leblanc; Peter Liu; Vivek Rao; Heather J Ross; Bruce Sussex
Journal:  Can J Cardiol       Date:  2012-11-30       Impact factor: 5.223

9.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Authors:  R Garg; S Yusuf
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

Review 10.  Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.

Authors:  Li-jun Hu; Yun-qing Chen; Song-bai Deng; Jian-lin Du; Qiang She
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335
View more
  2 in total

Review 1.  Higher medication doses in heart failure?

Authors:  James McCormack; Finlay A McAlister; Michael R Kolber
Journal:  Can Fam Physician       Date:  2017-01       Impact factor: 3.275

2.  Sacubitril-valsartan: novel therapy for heart failure.

Authors:  Evan Sehn; Terrence McDonald; Adrienne J Lindblad
Journal:  Can Fam Physician       Date:  2017-09       Impact factor: 3.275
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.